604 Clinical and molecular findings from a randomized phase II study of epigenetic priming with azacitidine and entinostat followed by nivolumab in previously treated metastatic non-small cell lung cancer

Kristen A Marrone; Blair V Landon; Michael J Topper; Hua-Ling Tsai; Archana Balan; Noushin Niknafs; Christopher Cherry; James White; Chen Hu; Joanne Riemer; Margaret Fitzpatrick; Patrick Forde; Christine Hann; Ronan Kelly; David Ettinger; Benjamin Levy; Jorge Nieva; James Herman; Victor Velculescu; Valsamo Anagnostou; Stephen Baylin; Julie Brahmer

doi:10.1136/jitc-2023-SITC2023.0604

Article info

Regular and Young Investigator Award Abstracts

Clinical Trial Completed

604 Clinical and molecular findings from a randomized phase II study of epigenetic priming with azacitidine and entinostat followed by nivolumab in previously treated metastatic non-small cell lung cancer

Authors

Kristen A Marrone Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA PubMed articles Google scholar articles
Blair V Landon Johns Hopkins University School of Medicine, Baltimore, MD, USA PubMed articles Google scholar articles
Michael J Topper Johns Hopkins University School of Medicine, Baltimore, MD, USA PubMed articles Google scholar articles
Hua-Ling Tsai Johns Hopkins University School of Medicine, Baltimore, MD, USA PubMed articles Google scholar articles
Archana Balan Johns Hopkins University School of Medicine, Baltimore, MD, USA PubMed articles Google scholar articles
Noushin Niknafs Johns Hopkins University School of Medicine, Baltimore, MD, USA PubMed articles Google scholar articles
Christopher Cherry Johns Hopkins University School of Medicine, Baltimore, MD, USA PubMed articles Google scholar articles
James White Resphera Biosciences, Baltimore, MD, USA PubMed articles Google scholar articles
Chen Hu Henlius, Shanghai, China PubMed articles Google scholar articles
Joanne Riemer Johns Hopkins University School of Medicine, Baltimore, MD, USA PubMed articles Google scholar articles
Margaret Fitzpatrick Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA PubMed articles Google scholar articles
Patrick Forde Johns Hopkins University School of Medicine, Baltimore, MD, USA PubMed articles Google scholar articles
Christine Hann Johns Hopkins University School of Medicine, Baltimore, MD, USA PubMed articles Google scholar articles
Ronan Kelly Baylor University Medical Center, Dallas, TX, USA PubMed articles Google scholar articles
David Ettinger Johns Hopkins University School of Medicine, Baltimore, MD, USA PubMed articles Google scholar articles
Benjamin Levy Johns Hopkins University School of Medicine, Baltimore, MD, USA PubMed articles Google scholar articles
Jorge Nieva University of Southern California, Los Angeles, CA, USA PubMed articles Google scholar articles
James Herman University of Pittsburgh, Pittsburgh, PA, USA PubMed articles Google scholar articles
Victor Velculescu Johns Hopkins University School of Medicine, Baltimore, MD, USA PubMed articles Google scholar articles
Valsamo Anagnostou Johns Hopkins University School of Medicine, Baltimore, MD, USA PubMed articles Google scholar articles
Stephen Baylin Johns Hopkins University School of Medicine, Baltimore, MD, USA PubMed articles Google scholar articles
Julie Brahmer Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA PubMed articles Google scholar articles

Citation

Marrone KA, Landon BV, Topper MJ, et al

Journal for ImmunoTherapy of Cancer 2023;11:doi: 10.1136/jitc-2023-SITC2023.0604

Online issue publication

November 02, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password